RemeGen Co., Ltd. submitted a resubmitted Monthly Return for the period ended 30 April 2026, confirming that no changes occurred in its authorised or issued share capital during the month.

Total authorised and registered share capital remained at 564.48 million shares, split between 208.58 million H-shares and 355.90 million A-shares, each with a par value of RMB 1.

Issued share capital was unchanged at 208.58 million H-shares and 355.70 million A-shares. The company continued to hold 194,144 A-shares as treasury stock, while no H-shares were held in treasury.

RemeGen affirmed compliance with Hong Kong’s 5 % minimum public-float requirement for its H-share class.

No share options, warrants, convertibles or other securities were issued, cancelled, or converted during the month. Under existing A-share employee incentive schemes, 2.18 million restricted shares remain available for future attribution; none were granted or vested in April.

The filing underscores RemeGen’s unchanged capital structure and regulatory adherence for the month.